Ianevski A - Search Results

1

Combinations of Host- and Virus-Targeting Antiviral Drugs Confer Synergistic Suppression of SARS-CoV-2.

Wagoner J, Herring S, Hsiang TY, Ianevski A, Biering SB, Xu S, Hoffmann M, Pöhlmann S, Gale M Jr, Aittokallio T, Schiffer JT, White JM, Polyak SJ. Wagoner J, et al. Among authors: ianevski a. Microbiol Spectr. 2022 Oct 26;10(5):e0333122. doi: 10.1128/spectrum.03331-22. Epub 2022 Oct 3. Microbiol Spectr. 2022. PMID: 36190406 Free PMC article.

2

SynergyFinder: a web application for analyzing drug combination dose-response matrix data.

Ianevski A, He L, Aittokallio T, Tang J. Ianevski A, et al. Bioinformatics. 2017 Aug 1;33(15):2413-2415. doi: 10.1093/bioinformatics/btx162. Bioinformatics. 2017. PMID: 28379339 Free PMC article.

3

Interactive visual analysis of drug-target interaction networks using Drug Target Profiler, with applications to precision medicine and drug repurposing.

Tanoli Z, Alam Z, Ianevski A, Wennerberg K, Vähä-Koskela M, Aittokallio T. Tanoli Z, et al. Among authors: ianevski a. Brief Bioinform. 2020 Jan 17;21(1):211-220. doi: 10.1093/bib/bby119. Brief Bioinform. 2020. PMID: 30566623 Free article.

4

Genome-wide off-targets of drugs: risks and opportunities.

Giri AK, Ianevski A, Aittokallio T. Giri AK, et al. Among authors: ianevski a. Cell Biol Toxicol. 2019 Dec;35(6):485-487. doi: 10.1007/s10565-019-09491-7. Epub 2019 Aug 20. Cell Biol Toxicol. 2019. PMID: 31432301 No abstract available.

5

SynToxProfiler: An interactive analysis of drug combination synergy, toxicity and efficacy.

Ianevski A, Timonen S, Kononov A, Aittokallio T, Giri AK. Ianevski A, et al. PLoS Comput Biol. 2020 Feb 3;16(2):e1007604. doi: 10.1371/journal.pcbi.1007604. eCollection 2020 Feb. PLoS Comput Biol. 2020. PMID: 32012154 Free PMC article.

6

SynergyFinder: a web application for analyzing drug combination dose-response matrix data.

Ianevski A, He L, Aittokallio T, Tang J. Ianevski A, et al. Bioinformatics. 2020 Apr 15;36(8):2645. doi: 10.1093/bioinformatics/btaa102. Bioinformatics. 2020. PMID: 32118251 Free PMC article. No abstract available.

7

SynergyFinder 2.0: visual analytics of multi-drug combination synergies.

Ianevski A, Giri AK, Aittokallio T. Ianevski A, et al. Nucleic Acids Res. 2020 Jul 2;48(W1):W488-W493. doi: 10.1093/nar/gkaa216. Nucleic Acids Res. 2020. PMID: 32246720 Free PMC article.

8

Prediction of drug combination effects with a minimal set of experiments.

Ianevski A, Giri AK, Gautam P, Kononov A, Potdar S, Saarela J, Wennerberg K, Aittokallio T. Ianevski A, et al. Nat Mach Intell. 2019 Dec;1(12):568-577. doi: 10.1038/s42256-019-0122-4. Epub 2019 Dec 9. Nat Mach Intell. 2019. PMID: 32368721 Free PMC article.

9

RUNX1 mutations in blast-phase chronic myeloid leukemia associate with distinct phenotypes, transcriptional profiles, and drug responses.

Adnan Awad S, Dufva O, Ianevski A, Ghimire B, Koski J, Maliniemi P, Thomson D, Schreiber A, Heckman CA, Koskenvesa P, Korhonen M, Porkka K, Branford S, Aittokallio T, Kankainen M, Mustjoki S. Adnan Awad S, et al. Among authors: ianevski a. Leukemia. 2021 Apr;35(4):1087-1099. doi: 10.1038/s41375-020-01011-5. Epub 2020 Aug 11. Leukemia. 2021. PMID: 32782381 Free PMC article.

10

Inhibition of Arenaviruses by Combinations of Orally Available Approved Drugs.

Herring S, Oda JM, Wagoner J, Kirchmeier D, O'Connor A, Nelson EA, Huang Q, Liang Y, DeWald LE, Johansen LM, Glass PJ, Olinger GG, Ianevski A, Aittokallio T, Paine MF, Fink SL, White JM, Polyak SJ. Herring S, et al. Among authors: ianevski a. Antimicrob Agents Chemother. 2021 Mar 18;65(4):e01146-20. doi: 10.1128/AAC.01146-20. Print 2021 Mar 18. Antimicrob Agents Chemother. 2021. PMID: 33468464 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

62 results

Search Page